ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

PatentVest Welcomes Dr. Sarah Cork as Senior Patent Attorney, Expanding Life Sciences IP Leadership


Sarah Cork Ph.D. - Patent Attorney

Dallas, TX, Sept. 24, 2025 (GLOBE NEWSWIRE) -- PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is pleased to announce that Dr. Sarah Cork is collaborating with the firm as a Senior Patent Attorney. Her arrival underscores PatentVest’s continued growth in the life sciences sector and strengthens its ability to deliver sophisticated intellectual property strategies that drive competitive advantage for clients.

Dr. Cork brings more than a decade of experience advising biotechnology, pharmaceutical, and medical device companies on complex intellectual property matters. With a Ph.D. in Neuroscience, she counsels clients on a wide range of sophisticated issues involving recombinant technology, biologic and small-molecule drugs, immunotherapies, gene therapy, medical devices, and AI-enabled precision medicine, with a focus on translational drug discovery. Her legal practice combines scientific expertise with extensive experience in patent litigation, prosecution, IP due diligence, and freedom-to-operate analyses. She has advised clients ranging from venture-backed startups developing first-in-class therapies to global enterprises defending multibillion-dollar portfolios.

Dr. Cork’s cases under the Biologics Price Competition and Innovation Act (BPCIA), early at-risk launches.  Her litigation background also spans Hatch-Waxman (ANDA) matters, post-grant proceedings, patent inventorship disputes, and drug product liability cases.

“Sarah’s arrival is a major win for our clients,” said Javier Chamorro, COO of PatentVest. “Her unique combination of deep scientific knowledge and proven litigation experience equips us to guide innovators through the most complex IP challenges—from protecting groundbreaking biologics to navigating regulatory pathways. Adding Sarah to our team strengthens PatentVest’s position as a trusted partner for life sciences companies and aligns with our broader mission to build enduring value for our clients and stakeholders.”

Beyond her legal practice, Dr. Cork is an active leader in the intellectual property and life sciences communities. She currently serves as the President of the Los Angeles Intellectual Property Law Association, is a member of the Pasadena Angels investor group, contributes as an SBIR grant reviewer, and entrepreneurs in life sciences incubators and accelerators.

About PatentVest
PatentVest, a division of MDB Capital Holdings (Nasdaq: MDBH), is the first integrated IP intelligence, strategy, and law firm designed to help visionary companies become technology leaders. By combining a proprietary database with a proven diligence process and deep technical expertise, PatentVest delivers actionable insights that protect innovation and empower clients to build lasting market leadership.

For more information or inquiries, please contact info@patentvest.com.

Attachment


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.40
+3.99 (1.63%)
AAPL  269.43
+0.96 (0.36%)
AMD  243.98
+10.44 (4.47%)
BAC  53.42
+0.22 (0.41%)
GOOG  290.59
+10.89 (3.89%)
META  631.76
+10.05 (1.62%)
MSFT  506.00
+9.18 (1.85%)
NVDA  199.05
+10.90 (5.79%)
ORCL  240.83
+1.57 (0.66%)
TSLA  445.23
+15.71 (3.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.